CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM NEW
Total 13F shares
344,665
Share change
-70,425
Total reported value
$678,788
Price per share
$1.97
Number of holders
13
Value change
-$138,025
Number of buys
4
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q3 2020

As of 30 Sep 2020, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 344,665 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, National Asset Management, Inc., The PNC Financial Services Group, Inc., MILLENNIUM MANAGEMENT LLC, BARCLAYS PLC, UBS Group AG, MORGAN STANLEY, and ROYAL BANK OF CANADA. This page lists 13 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.